RWM
ALDX icon

Raffa Wealth Management’s Aldeyra Therapeutics ALDX Stock Holding History

Raffa Wealth Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04K Hold
1,897
– – ﹤0.01% 643
2026
Q1 		$3.21K Hold
1,897
– – ﹤0.01% 638
2025
Q4 		$9.83K Hold
1,897
– – ﹤0.01% 382
2025
Q3 		$9.9K Hold
1,897
– – ﹤0.01% 366
2025
Q2 		$7.27K Hold
1,897
– – ﹤0.01% 441
2025
Q1 		$10.9K Hold
1,897
– – ﹤0.01% 299
2024
Q4 		$9.47K Buy
+1,897
New +$9.73K ﹤0.01% 337

Other funds holding ALDX

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Raffa Wealth Management's ALDX Position: Q2 2026 in Review

Raffa Wealth Management held its Aldeyra Therapeutics (ALDX) position steady in Q2 2026 at 1,897 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #643.

Raffa Wealth Management first reported a position in ALDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.9K in Q1 2025. 98 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Raffa Wealth Management held 1,897 shares of Aldeyra Therapeutics worth $4.04K as of Q2 2026.
  • Raffa Wealth Management left its Aldeyra Therapeutics share count unchanged in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #643 holding.
  • Raffa Wealth Management first reported a position in Aldeyra Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Raffa Wealth Management's Aldeyra Therapeutics position peaked at $10.9K in Q1 2025.
  • 98 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.